Ayr Wellness (OTCMKTS:AYRWF) Issues Earnings Results

Ayr Wellness (OTCMKTS:AYRWF) announced its quarterly earnings data on Thursday. The company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.12), Zacks reports. Ayr Wellness had a negative net margin of 48.17% and a negative return on equity of 25.30%. The firm had revenue of $113.96 million during the quarter, compared to analyst estimates of $114.10 million.

Ayr Wellness Stock Down 4.5 %

Shares of OTCMKTS:AYRWF opened at $0.21 on Friday. The stock has a market cap of $24.40 million, a price-to-earnings ratio of -0.09 and a beta of 1.70. The company has a quick ratio of 0.58, a current ratio of 1.59 and a debt-to-equity ratio of 0.76. Ayr Wellness has a 12-month low of $0.21 and a 12-month high of $3.46. The business’s 50 day moving average is $0.43 and its 200 day moving average is $1.08.

Wall Street Analyst Weigh In

A number of brokerages have commented on AYRWF. Atb Cap Markets cut Ayr Wellness from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 13th. Roth Capital raised Ayr Wellness to a “strong-buy” rating in a research note on Friday, November 8th. Finally, Roth Mkm reduced their price objective on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a research note on Thursday, November 14th.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.